Arrhythmogenic effects of antiarrhythmic drugs.
Furlanello
F
F
Divisione di Cardiologia e Centro Aritmologico, Ospedale S Chiara, Trento, Italy.
Dal Forno
P
P
Cozzi
F
F
Bettini
R
R
D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D005260:Female; D005424:Flecainide / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011405:Propafenone / Q000009:adverse effects; D012307:Risk Factors; D013015:Sotalol / Q000009:adverse effects; D013610:Tachycardia / Q000139:chemically induced*; D014700:Verapamil / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D013015:Sotalol; D014700:Verapamil; D005424:Flecainide; D000638:Amiodarone